oxprenolol has been researched along with Cardiovascular Diseases in 5 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials." | 5.22 | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. ( Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esler, M | 1 |
| Kjeldsen, SE | 1 |
| Pathak, A | 1 |
| Grassi, G | 1 |
| Kreutz, R | 1 |
| Mancia, G | 1 |
| Kendall, MJ | 1 |
| John, VA | 1 |
| Furberg, CD | 1 |
| Bekes, M | 1 |
| Matos, L | 1 |
| Rausch, J | 1 |
| Török, E | 1 |
3 reviews available for oxprenolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity | 2022 |
Oxprenolol: clinical pharmacology, pharmacokinetics, and pharmacodynamics.
Topics: Adolescent; Adult; Blood Pressure; Cardiovascular Diseases; Dose-Response Relationship, Drug; Female | 1983 |
Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Drug | 1974 |
1 trial available for oxprenolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; | 1985 |
1 other study available for oxprenolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiovascular Diseases; Drug Antagonism; H | 1972 |